Clinical Trial

Optokinetic Virtual Reality Stimulation in Unilateral Vestibular Hypofunction

Recruiting
View on ClinicalTrials.gov →
Summary
The study will be conducted on patients diagnosed with UVH who apply to Prof. Dr. Mete İşeri Ear, Nose and Throat Diseases Polyclinic and Güneşli Erdem Hospital Ear, Nose and Throat and Vestibular Rehabilitation Unit. Participants will be divided into 3 groups by simple randomization (closed envelope) method. To the vestibular rehabilitation group; A conventional rehabilitation program based on structured Cawthorne Cooksey exercises will be applied for 45 minutes once a week with the support of a physiotherapist for 8 weeks. To the optokinetic stimulation group; optokinetic stimulation will be given with virtual reality glasses, and to the combined group; Participants in the vestibular exercise group will receive additional optokinetic stimulation. The application will be done once a week for 8 weeks. Inclusion criteria for the study are; diagnosed with unilateral vestibular hypofunction with VNG test, between the ages of 18-65, class A+ in the System Usability Scale (SUS) and the percentage range being between 96-100%; Exclusion criteria for the study are; Bilateral vestibular hypofunction, visual impairment, neurological disorder and inability to communicate.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2024-07-22; most recent amendment 2026-03-02.
Trial Details
NCT Number NCT06517446
Lead Sponsor Istanbul Medipol University Hospital
Conditions Vestibular Hypofunction
Enrollment 48 participants
Start Date 2025-09-07
Primary Completion 2025-10-07 (estimated)
Study Completion 2026-05-07 (estimated)
Updated on ClinicalTrials.gov 2026-03-04